- MOQ3 Pack(s)
- MOQ3
- Supply TypeManufacturer, Exporter
- Preferred Buyer Location All Countries Except India
Saroglitazar is used in the treatment of Diabetic Dyslipidemia and hypertriglyceridemia with type 2 Diabetes Mellitus. Being a dual PPAR Agonist, Saroglitazar (Lipaglyn) helps in controlling Blood Glucose and Lipid Parameters especially high triglycerides and high non-HDL-Cholesterol. Lipaglyn effectively reduces Triglycerides and non-HDL-C and controlled high Blood Sugar, a typical situation in Insulin resistance condition.
View More Details